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Abstract
Background Obesity and metabolic syndrome (MetS) are key risk factors for type 2 diabetes and cardiovascular disease. 
Little information exists on the prevalence of obesity and MetS in Latin America and specifically in Ecuador. We aimed to 
estimate the prevalence of overweight, obesity, and MetS among adults in Ecuador.
Methods We analyzed data from a nation-wide population-based survey in Ecuador (ENSANUT-ECU) among 10,318 
participants (3684 men, 6634 women; age range: 18–59 years) conducted in 2012. Data related to residential location 
(urban versus rural), altitude (< 500, 500–1500 or > 1500 m above sea level (MASL)), region (highland, coast, amazon, or 
Galápagos), and socioeconomic status were collected. BMI, waist circumference, blood lipids, glucose, and blood pressure 
were measured by trained fieldworkers following standardized procedures.
Results The age-standardized prevalence of overweight was 39.5%; 22.3% was obese; and 31.2% had MetS. The prevalence 
of obesity, low HDL-cholesterol, and abdominal obesity were higher in women than in men, whereas men had a higher 
prevalence of hypertension (p < 0.05). Sex differences were not observed regarding the prevalence of combined MetS. 
Prevalence of both obesity and MetS was higher in urban areas, at low altitude regions (coast and Galapagos), and at high 
socioeconomic status (all p < 0.05).
Conclusions Prevalence of obesity and MetS in Ecuador are high. There are important demographic differences in the 
prevalence of MetS between Ecuadorian subpopulations that requires targeted research and prevention efforts, to hold and 
reduce the current public health problem of metabolic disorders.
Keywords Overweight · Obesity · Metabolic syndrome · Demographics
Introduction
There has been a dramatic epidemiologic transition from 
infectious diseases to non-communicable diseases in the past 
decades in developing countries [1]. This transition could 
be explained by the increased overweight prevalence [2, 3] 
which is associated with higher risk of developing metabolic 
syndrome (MetS), cardiovascular diseases (CVD), and dia-
betes mellitus type 2 (DM2), which are currently the lead-
ing causes of morbidity and death in Latin America and 
worldwide [4–6].
In Latin America, Mexico has the highest prevalence of car-
diometabolic risk factors, with an estimated 67% of the popula-
tion being overweight or obese [3], and 50% in the population 
older than 20 years having MetS [7]. Meanwhile, the preva-
lence of overweight and obesity is also high in other Latin-
American countries, with estimates varying from 20 to 50% 
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[3, 8], while the prevalence of MetS was recently estimated to 
be around 25% in the population between 18 and 65 years old, 
where low HDL-cholesterol and abdominal obesity were the 
most frequent components [7]. This high prevalence of MetS 
could be explained by the epidemiological transition, globaliza-
tion, migration (from rural to urban areas), and corresponding 
changes in patterns of physical activity to a more sedentary 
life style, and shifts from diets based on natural or minimally 
processed foods and high in Andean grains and vegetables to 
a diet high in processed and ultra-processed foods and sugar-
sweetened beverages [2, 9]. For Ecuador, there is not much 
information in a national context; data available so far are based 
only on the population of the capital city, Quito for which it was 
reported that 20% of women and 7.5% of men between 25 and 
64 years of age have MetS [10]. In another study in a population 
older than 65 years in Quito, the prevalence of MetS was esti-
mated to be 40% [11]. However, like other Andean nations in 
Latin America, Ecuador has a huge diversity with four different 
geographical regions (highlands, amazon, coast, and Galapagos 
Islands), each one with its own foods habits, altitude [from 0 
to over 3000 m above sea level (MASL)], genetic background, 
economic status, and levels of urbanization [12]. Furthermore, 
there are several different ethnic groups in Ecuador with most 
being mestizos (Indian with European mix), 32 distinct Amer-
indian tribes, African descendants, Mulatos (African descend-
ants with European mix), and Caucasian populations in low 
proportion [12]. A recent survey in China has shown a wide 
variability in MetS prevalence between rural and urban areas, 
and between regions [13], but whether this is also the case for 
Ecuador this is unknown. Consequently, it is important to estab-
lish the metabolic condition of Ecuadorian population taken 
in consideration socioeconomic status, geographical location, 
altitude, and ethnic origin that will allow a better estimation of 
the population burden of MetS and the implementation of new 
and more effective prevention strategies.
To achieve this goal, the Health Ministry of Ecuador con-
ducted a large national health and nutrition survey (hereafter, 
ENSANUT-ECU), in which details on the socioeconomic sta-
tus, nutrition, and health of the Ecuadorian population between 
the age of 0–59 years were evaluated.
Using data obtained in the ENSANUT-ECU survey, we 
aim to address the distribution and prevalence of overweight 
and MetS, and to study differences by gender, socioeconomic 




The nation-wide cross-sectional population-based survey, 
ENSANUT-ECU, was based on a multi-stage, stratified 
sample design in nationally representative population aged 
0–59 years in Ecuador [14, 15]. The population was strati-
fied by rural and urban areas, regions, and provinces. For 
each province, 64 census tracts were initially preselected 
from which 12 occupied households were selected by sim-
ple random sampling. For 57,727 individuals from 19,803 
households, information on sociodemographic character-
istics and anthropometric measurements were collected. 
From a random subsample of 14,989 persons, a venous 
blood and urine specimens were collected.
The ENSANUT-ECU study was approved by the Insti-
tutional Review Board of the San Francisco de Quito Uni-
versity. All participants signed informed consent forms, 
and all data were pseudonymized during data entry and 
analysis [14].
For the current study, participants aged 18–59 years 
with complete information on sociodemographic and 
biochemistry data were selected. This resulted in a study 
population of 10,318 participants (3684 men and 6634 
women). Data from 12 questionnaires were collected, from 
which for the current study, the following data were used: 
socioeconomic and demographic information; data related 
to location (urban or rural), and altitude [< 500, 500–1,500 
or > 1,500 m above the see level (MASL)], region (high-
land, coast, amazon, or Galápagos). In addition, we used 
data that were collected from measurements: anthropom-
etry, blood pressure; and the following biomarkers: total 
cholesterol, HDL-cholesterol, triglycerides, and fasting 
plasma glucose.
Data collection
Applied structured questionnaires and measurements to 
participants in the selected households was performed by 
trained fieldworkers with the use of standardized proce-
dures, protocols, and equipment [16]. Height was meas-
ured in subjects using portable stadiometers to the near-
est 0.1 cm. Abdominal circumference was measured with 
standard tape measure to the nearest 0.1 cm. Portable elec-
tronic scales were used to measure weight in adults to the 
nearest 0.1 kg. Anthropometric data were collected twice 
for each variable with an interval of 5–10 min, to ensure 
reliability, and the mean of the two measurements was 
used. Blood pressure was measured twice using a digital 
sphygmomanometer. If there was a difference of ± 0.5 kg 
in weight, ± 0.5 cm in height or abdominal circumference, 
or ± 10 mmHg in blood pressure, a third measure was 
taken, and the two closest values were used to calculate 
the mean. To ensure the quality of the data, supervisors 
re-measured weight and height of participants in every 
tenth household, and interviewers were retrained every 
11 days of fieldwork. National identity cards were used 
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to verify participants’ age. Using the standardized pro-
cedures, venous blood and urine samples for biochemical 
determinations were collected [14]. Blood concentrations 
of total cholesterol, HDL-cholesterol, triglycerides, and 
glucose were measured using an automated enzymatic-
colorimetric assay Modular Pre-Analytics Evo analyzer 
(Roche Diagnostics).
Definitions of overweight, metabolic syndrome, 
and triads
BMI was calculated as weight in kilograms divided by the 
square of height in meters (kg/m2). Underweight was defined 
as a BMI < 18.5 kg/m2, overweight as BMI ≥ 25 and < 30 kg/
m2, and obesity as BMI ≥ 30 kg/m2 [17]. MetS was defined 
according to the harmonized criteria of a joint interim state-
ment of the International Diabetes Federation task force [18] 
as the presence of three or more of the following risk factors: 
elevated waist circumference (men ≥ 90, women ≥ 80 cm), 
elevated triglycerides (≥ 150  mg/dL), reduced HDL-C 
(≤ 40  mg/dL), elevated blood pressure (systolic ≥ 130 
and/or diastolic ≥ 85 mm Hg), or elevated fasting glucose 
(≥ 100 mg/dL). In addition to MetS, we defined combinatory 
dangerous triads, which have been shown to be associated 
with higher CVD and overall mortality, as the combination 
of abdominal obesity, high blood pressure, and hyperglyce-
mia and the combination of low HDL, high blood pressure, 
and hypertriglyceridemia [6].
Sociodemographic factors
For obtaining an approximate index of economic welfare, 
a factor analysis was used based on 42 variables. The vari-
ables used in this procedure were those related to home 
ownership, household equipment, and characteristics of 
housing variables, such as ownership of kitchen equip-
ment, laptop, desktop, conventional television, led televi-
sion, or a DVD player, on which information was obtained 
from the questionnaires. Once estimated, the model builds 
a score by means of a regression. With this technique, an 
index of economic welfare was obtained, which summa-
rizes the structure of variance and covariance of all the 42 
variables included. The score was estimated at the level 
of the household. A higher score represents a better eco-
nomical position for that household. We categorized the 
score into quintiles that were then used as a categorical 
variable. Those households in the lowest quintile (Q1) are 
those households with the poorest economic conditions 
in terms of characteristics of housing and holding assets, 
while those in the highest quintile (Q5) represent house-
holds with better economic conditions [14].
The altitude of the households was determined by 
GPS devices and was categorized into meters above sea 
level (MASL). Ecuador has four regions: the coast region 
is located between the Pacific Ocean by the east and the 
Andes mountains by the west; the highlands correspond to 
the Andean mountains that cross Ecuador from South to 
North and divided the territorial land in three regions; the 
Amazon region is founded between the east border of the 
Andes mountains and the borders of Colombia and Peru in 
the west; and the Galapagos Islands that is the archipelago 
de Galapagos (see Fig. 1, which summarizes the metabolic 
abnormalities of each region). The coast and the Galapagos 
represent 3222 of 3279 inhabitants at 0–500 MASL region, 
1333 individuals of the Amazon also belong to the 2114 
subjects from 501–1500 MASL, and the 4037 participants 
from the highlands are also part of the group of 4925 liv-
ing > 1501 MASL. The capitals of the provinces and the 
head of the cantons (Provinces are divided in cantons) are 
considered urban areas.
Statistical analysis
Both crude and age-standardized prevalence of overweight, 
obesity, and Mets were calculated using the overall 2010 
population census distribution for Ecuador [19]. We strati-
fied age standardization by gender to be able to compare 
men and women. Data are presented as percentages, means 
with SDs, or medians with range, depending the type of 
analysis. We provide the estimates of the prevalence of over-
weight, obesity, and Mets in our whole-study population and 
stratified by gender, age, area of residence, region, altitude, 
ethnicity, and socioeconomic status. For the age-stratified 
analysis, we split the population into four age groups: 18–29, 
30–39, 40–49, and 50–59 years old. We compared differ-
ences between groups using Chi-square tests, t tests, and 
ANOVA depending the nature of the variable analyzed, 
and we examined correlations with Spearman’s test. Fig-
ures were performed using GraphPad Prism version 5.00 for 
Windows, GraphPad Software, San Diego, California, USA.
Results
General description of the study population
Table 1 describes the general characteristics of the study 
population stratified by the presence or absence of MetS 
and by sex. As expected, age, weight, waist circumfer-
ence, BMI, lipids, and fasting plasma glucose were on 
average higher in the population with MetS.
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Overweight, obesity and MetS by age, sex, 
and ethnic origin.
Overweight or obesity was present in 57% of men and in 
65.7% of women (Fig. 2). This higher prevalence among 
women as compared to men was mainly driven by a higher 
prevalence of obesity (BMI > 30) (25.9% versus 15.4% in 
men, p < 0.001) (Fig. 2). Despite the higher prevalence 
of overweight and obesity in women, there was no sig-
nificant difference in MetS between genders, with 31.5% 
of men and 30.8% of women having MetS (Fig. 2). MetS 
prevalence was higher in older adults and was three times 
higher in the age groups 40–49 and 50–59 (45.4% and 
49.1%, respectively), in comparison with the age group 
of 18–29 years (16.1%) (Table 1). The prevalence of MetS 
was twice higher in mestizos and other ethnic groups than 
the indigenous population (Table 1).
MetS by sex
Table 2 shows that men had a lower prevalence of abdominal 
obesity, low HDL-cholesterol, and overweight and obesity, 
whereas women had lower prevalence of hypertriglyceri-
demia and hypertension. The age-standardized prevalence 
of the cumulative numbers of the metabolic abnormali-
ties of the MetS shows that only one-third of the female 
population have no abnormalities compared to one quarter 
of the male population. In line with this, men more often 
had more abnormalities than women (Table 3) (see Table, 
Online Resource 1, which illustrates the age-standardized 
prevalence of the accumulative risk factors of the metabolic 
syndrome by subregion, area, altitude, region, and socioeco-
nomic quintiles and by gender). 
Overweight, obesity and MetS in urban versus rural 
areas
The population living in urban areas had higher MetS 
(33.7%) than those in rural areas (27.0%) (p < 0.001). This 
Fig. 1  Figure of the map of Ecuador that summarizes the significant metabolic abnormalities on each region. All the metabolic abnormalities 
highlighted on each region are significant against at least another region (p < 0.05)
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difference between urban and rural areas was especially pro-
nounced for men (34.9% of men in urban versus 25.2% of 
men in rural areas) (Table 1). The prevalence of overweight 
and obesity and of all MetS components, except for low 
HDL, was higher in urban populations. These differences 
were again mainly based on differences in men living in 
urban versus rural areas, while urban versus rural women 
differed to a smaller extent (see Table, Online Resource 
2, which describes the age-standardized prevalence of the 
individual components of the metabolic syndrome and 
Table 1  Characteristics of participants by gender and by metabolic syndrome status
SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose










Age (years)c (10,318) 30 (41) 38 (41) 32 (41) 39 (41)
Age groupsb (10,318)
18–29 (3711) 82.6% (1217) 17.4% (257) 84.8% (1897) 15.2% (340)
30–39 (3334) 64.4% (709) 35.6% (392) 68.4% (1527) 31.6% (706)
40–49 (2540) 53.9% (435) 46.1% (372) 55.0% (953) 45.0% (780)
50–59 (733) 53.6% (162) 46.4% (140) 49.0% (211) 51.0% (220)
Weight (kg)a (10,318) 66.7 (10.9) 79.9 (11.8) 60.3 (11.3) 69.7 (12.1)
Height (m)a (10,318) 1.7 (0.1) 1.7 (0.1) 1.5 (0.1) 1.5 (0.1)
Waist circumference (cm)a (10,318) 84.7 (9.5) 98.5 (9.1) 84.6 (10.4) 94.9 (9.9)
SBP (mmHg)a (10,318) 118.5 (10.7) 128.1 (14.0) 111.4 (11.2) 122.3 (15.8)
DBP (mmHg)a (10,318) 73.5 (8.5) 80.7 (9.9) 69.2 (8.1) 76.0 (10.3)
Total cholesterol (mg/dL)a (10,318) 174.0 (36.5) 192.0 (38.0) 171.3 (35.9) 190.0 (36.6)
LDL-cholesterol (mg-dL)a (10,085) 105.5 (31.6) 115.4 (33.8) 104.2 (29.8) 115.1 (32.5)
HDL-cholesterol (mg/dL)a (10,318) 45.8 (11.0) 34.4 (7.1) 48.4 (12.1) 38.3 (7.9)
Triglycerides(mg/dL)c (10,318) 101 (374) 199 (351) 88 (349) 173 (365)
Glucose (mg/dL)a (10,318) 86.9 (11.5) 100.7 (37.1) 86.2 (11.0) 102.0 (38.8)
BMI (kg/m2)a (10,318) 24.5 (3.5) 29.2 (3.6) 26.0 (4.4) 30.2 (4.8)
BMI groups (Kg/m2)b (10,318)
Underweight (< 18.5) 96.5% (55) 3.5% (2) 97.8% (90) 2.2% (2)
Normal (18.5–25) 93.5% (1427) 6.5% (100) 90.6% (1983) 9.4% (206)
Overweight (25–30) 58.2% (891) 41.8% (640) 65.1% (1712) 34.9% (916)
Class I obesity (30–35) 26.5% (126) 73.5% (350) 50.3% (633) 49.7% (626)
Class II/III obesity (35–40) 26.1% (24) 73.9% (68) 36.6% (169) 63.4% (293)
Ethnic originb (10,318)
Indigenous (952) 84.5% (277) 15.5% (51) 76.6% (478) 23.4% (146)
Mestizo (8377) 66.5% (1971) 33.5% (992) 68.1% (3685) 31.9% (1729)
Others (989) 70.0% (275) 30.0% (118) 71.3% (425) 28.7% (171)
Altitudeb (10,318)
0–500 m (4372) 64.2% (1043) 35.8% (581) 67.0% (1840) 33.0% (908)
501–1500 m (1819) 71.3% (427) 28.7% (172) 73.2% (893) 26.8% (327)
> 1500 m (4127) 72.1% (1053) 27.9% (408) 69.6% (1855) 30.4% (811)
Sub regionsb (10,318)
Highlands (4925) 71.1% (1240) 28.9% (504) 69.5% (2210) 30.5% (971)
Coast (2957) 63.7% (722) 36.3% (412) 65.9% (1201) 34.1% (622)
Amazon (2114) 72.0% (502) 28.0% (195) 74.0% (1049) 26.0% (368)
Galapagos (322) 54.1% (59) 45.9% (50) 60.1% (128) 39.9% (85)
Areab (10,318)
Urban (6565) 65.1% (1559) 34.9% (837) 67.6% (2818) 32.4% (1351)
Rural (3753) 74.8% (964) 25.2% (324) 71.8% (1770) 28.0% (695)
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overweight and obesity by area, altitude, region, and socio-
economic quintiles and by gender). In line with this, urban 
populations had higher prevalence of 3, 4, and 5 abnormali-
ties, again mainly explained by differences in men (Table 3) 
(see Table, Online Resource 2, which describes the age-
standardized prevalence of the individual components of the 
metabolic syndrome and overweight and obesity by area, 
altitude, region, and socioeconomic quintiles and by gender).
Overweight and MetS by altitude
Population that lived 0–500 MASL, had the highest preva-
lence of MetS (p < 0.001), hypertension (p < 0.001) and 
hyperglycemia (p < 0.001) of all altitude regions (Tables 2 
and 3), whereas those living 501–1500 MASL had the 
highest prevalence of low HDL (p < 0.001) and the lowest 
prevalence of hypertension, especially in women (see Table, 
Online Resource 2, which describes the age-standardized 
prevalence of the individual components of the metabolic 
syndrome and overweight and obesity by area, altitude, 
region, and socioeconomic quintiles and by gender). The 
population living 501–1500 MASL had a significant higher 
prevalence of two metabolic abnormalities, while the popu-
lation living 0–500 MASL had significant higher prevalence 
of four abnormalities both in men and women (Table 4).
Overweight and MetS by region
In line with the results for the low altitude, a higher preva-
lence, both in men and women, of MetS, hypertension, and 
hyperglycemia were found in the coast and in the Galapa-
gos regions, as compared to the other regions (Tables 2 and 
3). Also, prevalence of overweight or obesity was higher 
in the Galapagos region (74.8%) than in the other regions 
(61.5–62.8%) (Fig. 3, Table 3) (see Table, Online Resource 
2, which describes the age-standardized prevalence of 
the individual components of the metabolic syndrome 
and overweight and obesity by area, altitude, region, and 
socioeconomic quintiles and by gender). The coast and the 
Galapagos also had the highest prevalence of four and five 
cumulative abnormalities (Table 4). The lowest prevalence 
of MetS and that of most of the individual components of 
the MetS were observed in for the population living in the 
Amazon (26.6% for MetS) (Tables 2, 3 and 4). In contrast, 
the Amazon region had the highest prevalence of low HDL 
(66.6%) of all regions, mainly among women living in the 
Amazon (75.7%). Due to the unexpected high prevalence 
of low HDL-cholesterol, a correlation between cholesterol 
and HDL levels was performed in the amazon population. 
There was a positive correlation between total cholesterol 
and HDL-cholesterol only in women (Fig. 3).
Overweight and MetS by economic status
The lowest quintile (Q1) of economic status had the low-
est prevalence of overall MetS (Table 2), and of overweight 
or obesity and each of the individual MetS components 
Fig. 2  Age-standardized prevalence of overweight, obesity, and meta-
bolic syndrome (MetS) in adults aged 18–59 in Ecuador. *p < 0.001
Table 2  Crude and age-standardized prevalence of the metabolic syn-
drome
Results are age-standardized rate (95% CI)
*Significant differences (p value < 0.05) compared to rural, 501–1500 
and > 1500, Highland and Amazon, and to Q1. aSignificant differ-
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(Table 3). As presented in Table 2 and Fig. 4, there is a 
gradient of MetS by economic status, where Q4 showed the 
highest prevalence. When comparing SES and MetS strati-
fied by gender, we see that among men, Q1 showed the low-
est prevalence but differences between the other quintiles 
(Q2–Q5) were generally small. In women, MetS showed a 
lower prevalence in Q1 but also in quintile Q5, compared 
to the other quintiles (Fig. 4 and Table, Online Resource 
2, which describes the age-standardized prevalence of the 
individual components of the metabolic syndrome and over-
weight and obesity by area, altitude, region, and socioeco-
nomic quintiles and by gender).
The dangerous triads
The dangerous triads were more prevalent in men (10.5 vs 
5.6), urban population (5.8 vs 2.9), and at low altitude (5.9 
vs 2.2 and 3.2), whereas the lowest prevalence was in the 
amazon region (1.8 vs 3.4 Highlands, 6.8 Coast, and 7.1 
Galapagos) and in the lower socioeconomic quintile Q1 (4.6 
vs 8.2 Q4, or 8.1 Q5) (see Table, Online Resource 3, which 
shows the crude and age-standardized prevalence of the dan-
gerous triads).
Discussion
We showed that MetS is present overall in more than 30% 
of the adult population of Ecuador between 18 and 59 years 
old, and that around 85% of the population has at least one 
metabolic abnormality defined as either altered glucose 
metabolism, dyslipidemia, high blood pressure, or abdomi-
nal obesity. The prevalence of overweight, obesity, and 
MetS triple with age, where the prevalence from 18 to 29 is 
around 16% and increases to approximately 50% at the age 
group 50–59. Abdominal obesity and low HDL-cholesterol 
are the most common metabolic abnormalities in Ecuador, 
with approximately 65% and 60%, respectively. Besides 
highlighting the difficult public health problem that the over-
weight and MetS represent in Ecuador, in this study, we 
address in this study significant differences between popu-
lations that should be taken into consideration to establish 
population-based strategies to combat this serious health 
problem with strong economic implications.
The high prevalence of overweight and obesity in the gen-
eral Ecuadorian adult population is particularly important in 
the Galapagos and the Coast regions. These regions also had 
around twice the prevalence of the dangerous triads. This 
Table 3  Crude and age-standardized prevalence of the individual components of the metabolic syndrome and overweight and obesity
Results are age-standardized rate (95% CI). Significant differences (p value < 0.05) compared to  menβ,  women¶,  rural¶, 501–1500 
and > 1500‡, > 1500‼, 501–1500α,  Amazon+, Highland and Amazon*, Highland and  Coastπ, and to  Q1‡
Individual components of the metabolic syndrome
Abdominal obesity Hypertriglyceridemia Low HDL cholesterol High blood pressure Hyperglycemia BMI > 25 kg/m2
Crude 69.2 (67.5–70.8) 34.3 (33.1–35.5) 59.8 (58.4–61.3) 22.8 (21.8–23.8) 18.9 (18.0–19.9) 66.5 (64.9–68.1)
Gender
Men 46.6 (44.4–48.9) 39.5 (37.5–41.5)¶ 45.9 (43.7–48.1) 27.1 (25.4–28.8)¶ 16.4 (15.0–17.7) 57.4 (54.9–59.8)
Women 74.0 (71.9–76.0)β 26.2 (24.9–27.4) 67.9 (65.9–69.9)β 14.6 (13.6–15.6) 15.2 (14.2–16.1) 64.6 (62.6–66.5)β
Area
Urban 66.0 (64.0–68.0)¶ 33.0 (31.6–34.4)¶ 60.7 (58.9–62.6) 20.5 (19.3–21.6)¶ 17.2 (16.2–18.2)¶ 65.0 (63.0–66.9)¶
Rural 60.2 (57.8–62.7) 27.1 (25.4–28.7) 58.1 (55.7–60.5) 16.9 (15.6–18.3) 13.0 (11.8–14.2) 56.6 (54.2–59.0)
Altitude
0–500 65.6 (63.2–68.0) 30.6 (29.0–32.2) 60.2 (57.9–62.5) 21.2 (19.8–22.6)‡ 20.4 (19.0–21.7)‡ 63.3 (60.9–65.6)
501–1500 64.0 (60.4–67.7) 29.6 (27.1–32.1) 65.4 (61.7–69.1)‼ 11.3 (9.8–12.9) 11.0 (9.5–12.5) 62.6 (59.0–66.2)
> 1500 63.2 (60.8–65.7) 31.6 (29.9–33.3) 58.5 (56.2–60.8) 17.7 (16.4–19.0)α 10.6 (9.7–11.6) 61.9 (59.5–64.3)
Subregion
Highland 63.8 (61.5–66.0) 31.9 (30.4–33.5) 58.8 (56.6–60.9) 17.7 (16.5–18.8)+ 11.3 (10.3–12.2) 62.2 (60.0–64.4)
Coast 65.2 (62.2–68.1) 30.6 (28.6–32.6) 58.3 (55.5–61.0) 23.3 (21.5–25.0)* 23.1 (21.4–24.8)* 62.8 (60.0–65.7)
Amazon 62.9 (59.5–66.3) 28.7 (26.4–31.0) 66.6 (63.1–70.1)π 10.9 (9.5–12.3) 9.1 (7.8–10.4) 61.5 (58.2–64.9)
Galapagos 76.4 (66.9–85.9)* 29.8 (23.9–35.8) 65.2 (56.4–74.0) 22.4 (17.2–27.5)+ 30.8 (24.7–36.8)* 74.8 (65.4–84.3)*
Economic status quintile
Q1 55.6 (52.5–58.6) 23.9 (21.8–25.9) 55.9 (52.8–59.0) 16.2 (14.5–17.8) 13.1 (11.6–14.6) 53.3 (50.2–56.3)
Q2 65.7 (62.4–69.0)‡ 29.5 (27.3–31.7)‡ 61.1 (57.9–64.3) 17.5 (15.8–19.2) 14.3 (12.7–15.8) 62.8 (59.5–66.0)‡
Q3 66.5 (63.0–70.0)‡ 33.0 (30.5–35.5)‡ 63.3 (59.9–66.7)‡ 18.7 (16.9–20.6) 15.7 (14.0–17.4) 64.1 (60.7–67.5)‡
Q4 68.5 (64.8–72.1)‡ 35.1 (32.5–37.8)‡ 62.7 (59.1–66.2)‡ 19.5 (17.5–21.4) 16.9 (15.1–18.7)‡ 68.4 (64.7–72.0)‡
Q5 67.1 (63.2–70.9)‡ 34.1 (31.3–36.8)‡ 59.6 (56.0–63.2) 18.8 (16.7–20.8) 14.5 (12.7–16.3) 66.4 (62.6–70.2)‡
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finding in coastal areas is puzzling, since the diet is rich in 
sea food [20], which is considered to be a beneficial factor 
preventing the MetS [21]. Apparently other lifestyle factors 
(e.g., a high consumption of excess sugar and processed 
foods, a high intake of carbs and salt, and a sedentary and 
urbanized lifestyle in coastal cities) overrule the beneficial 
diet rich in sea food. Consequently, the coast and Galápa-
gos regions have the highest risk of morbidity and mortality 
of the Ecuadorian population [6]. Preventive efforts should 
be mainly focused on reducing the blood pressure, highly 
prevalent in these regions, which is a key risk factor for a 
CVD event.
The population living in the Amazon region had the low-
est prevalence of the individual metabolic syndrome MetS 
components, except for low HDL-cholesterol for which this 
region had the highest prevalence among all the altitudes. 
Table 4  Crude and age-standardized prevalence of one or more components of the metabolic syndrome
Results are age-standardized rate (95% CI). Significant differences (p value < 0.05) compared to  women¶,  menπ,  urbanβ,  rural¶, 501–1500 
and > 1500‡, 0–500 and > 1500‼, 501–1500α,  Galapagosδ, Highland and  Coast±, Highland and  AmazonΔ, Q2–Q5*, Q3 and  Q4ϕ,  Q1‡ and to Q1 
and  Q2κ
Accumulative risk factors of the metabolic syndrome
0 1 2 3 4 5
Crude 13.2 (12.6–13.9) 22.3 (21.5–23.2) 28.6 (27.5–29.6) 21.1 (20.2–22.0) 11.7 (10.9–12.4) 3.1 (2.7–3.5)
Gender
Men 25.2 (23.6–26.8)¶ 22.8 (21.3–24.3) 19.9 (18.5–21.4) 18.2 (16.8–19.6) 11.2 (10.1–12.3)¶ 2.7 (2.1–3.2)
Women 10.2 (9.4–11.0) 25.5 (24.2–26.7) 33.6 (32.2–35.0)π 20.0 (18.9–21.0) 8.6 (7.9–9.3) 2.2 (1.8–2.6)
Area and altitude
Urban 14.7 (13.8–15.6) 23.1 (21.9–24.3) 28.5 (27.3–29.8) 20.3 (19.2–21.3)¶ 10.5 (9.7–11.3)¶ 2.9 (2.4–3.3)¶
Rural 17.8 (16.4–19.1)β 26.7 (25.1–28.4)β 28.5 (26.8–30.2) 17.8 (16.5–19.1) 7.7 (6.8–8.6) 1.5 (1.1–1.8)
Altitude
0–500 14.5 (13.4–15.7) 23.5 (22.0–24.9) 27.9 (26.3–29.5) 20.3 (19.0–21.6) 11.1 (10.1–12.0)‡ 2.7 (2.2–3.2)α
501–1500 16.2 (14.3–18.0) 23.6 (21.3–25.8) 32.9 (30.2–35.5)‼ 18.8 (16.8–20.8) 7.1 (5.9–8.3) 1.4 (0.9–2.0)
> 1500 16.8 (15.5–18.1) 25.8 (24.3–27.4) 27.9 (26.3–29.5) 19.8 (18.4–21.1) 7.9 (7.1–8.8) 1.8 (1.4–2.2)
Subregion
Highland 16.8 (15.7–18.0)δ 25.1 (23.7–26.5)δ 28.2 (26.7–29.7) 19.7 (18.4–20.9) 8.4 (7.6–9.2) 1.9 (1.5–2.3)
Coast 14.4 (13.0–15.7) 23.6 (21.9–25.4) 27.1 (25.2–28.9) 20.3 (18.6–21.9) 11.6 (10.3–12.8)Δ 3.1 (2.5–3.8)Δ
Amazon 15.9 (14.2–17.5) 25.1 (23.0–27.3)δ 32.4 (30.0–34.8)± 19.2 (17.4–21.1) 6.3 (5.2–7.4) 1.1 (0.6–1.5)
Galapagos 10.9 (7.3–14.5) 17.7 (13.1–22.3) 29.5 (23.6–35.4) 22.7 (17.5–27.9) 16.5 (12.0–20.9)Δ 2.8 (1.0–4.6)
Economic status
Q1 19.7 (17.9–21.6)* 28.3 (26.1–30.5)ϕ 28.3 (26.1–30.5) 16.1 (14.4–17.7) 6.3 (5.2–7.3) 1.3 (0.8–1.7)
Q2 15.2 (13.6–16.8) 24.6 (22.6–26.7) 29.8 (27.6–32.1) 19.5 (17.7–21.3) 9.1 (7.9–10.4)‡ 1.8 (1.2–2.3)
Q3 14.3 (12.6–15.9) 22.6 (20.6–24.7) 28.8 (26.5–31.1) 22.3 (20.3–24.3)‡ 9.9 (8.6–11.3)‡ 2.1 (1.4–2.7)
Q4 14.2 (12.5–15.8) 22.1 (20.0–24.2) 27.8 (25.4–30.1) 22.0 (19.9–24.1)‡ 10.6 (9.2–12.1)‡ 3.3 (2.5–4.1)κ
Q5 14.8 (13.0–16.6) 23.8 (21.5–26.1) 29.0 (26.5–31.6) 19.8 (17.8–21.9)‡ 10.1 (8.6–11.5)‡ 2.5 (1.8–3.2)‡
Fig. 3  Correlation of total 
cholesterol and HDL. a In men, 
Spearman’s correlation coef-
ficient 0.04, p 0.24, and b in 
women, Spearman’s correlation 
coefficient 0.26, p < 0.001
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Since the Amazon region is less urbanized, we may specu-
late that a more rural lifestyle may have a beneficial effect 
to prevent the development of the MetS. Consequently, a 
more active lifestyle using a diet low in cholesterol and 
based on natural ingredients without usage of excess sugar 
and processed foods plays a role in MetS low prevalence 
in the Amazon area. The correlation of low total choles-
terol with low HDL-cholesterol levels found in the Amazon 
population (be it only in women) could then also explain the 
high prevalence of low HDL-cholesterol, since cholesterol 
is necessary in the synthesis of HDL [22]. Another possible 
mechanism of this special lipidemic profile of the Amazon 
indigenous population could be a genetic variation causing 
lower HDL-cholesterol levels, as has been described previ-
ously in the literature [23].
Besides the differences in regions, this study showed a 
higher prevalence of MetS and overweight in urban com-
pared to rural areas. This is in agreement with evidence from 
the other studies on a higher prevalence in urban areas, in 
both developed and developing countries [13, 24]. How-
ever, a recent publication on Iranian population described 
an increased prevalence of MetS and its components in rural 
compared to urban areas [25]. Inadequate physical activ-
ity, higher intake of sugar-enriched beverages and fast food, 
and low intake of fruit and vegetables are some factors that 
take part in urbanization lifestyle that account for the high 
prevalence of MetS and its components found in the urban 
population.
With respect to socioeconomic status, the population 
with the lowest socioeconomic status had the lowest preva-
lence of MetS and almost all the individual components, 
while the high-income population had the worst metabolic 
profile. A similar SES pattern was found in a nation-wide 
study performed in Mexico [26]. In our study, however, 
women in the highest and lowest socioeconomic quintiles 
both had similar low metabolic risks, whereas for men, only 
the lowest socioeconomic status was associated with bet-
ter metabolic health (Fig. 5). This crucial difference in SES 
between women and men was not reported in the Mexican 
population [26]. In this study, only men showed the charac-
teristic pattern of undeveloped countries where belonging 
to a high-income class is correlated to the development of 
MetS [27, 28], while women agreed with a protective effect 
of high social class to MetS described elsewhere [29–32]. 
A difference between men and women in this respect has 
been reported previously [33, 34]. It is important to highlight 
that in developed countries, there is a transition where the 
higher socioeconomic class is reducing their metabolic risk, 
while it is increasing in lower social classes [32, 35], likely 
illustrating the adoption of a healthier lifestyle in the more 
effluent classes. We hypothesize that this change is already 
happening in Ecuador, since the women in the highest socio-
economic class showed a lower prevalence of MetS com-
pared to the high–middle class which showed the highest 
prevalence. Unequal health access and social benefits will 
hamper the possible positive effects of preventive govern-
ment measures to the population with the low income and 
middle income, resulting in a shift of better health in higher 
rather than lower socioeconomic groups.
In Latin America, there are a few nationally representa-
tive surveys addressing cardiometabolic risk factors [7, 
8]. Obesity, high blood pressure, dyslipidemia, and dia-
betes are major public health problems globally. Despite 
this, there is still not enough information on the variation 
of the prevalence between and within countries and on the 
changes of these risk factors in time. To better understand 
this global pandemic, it will be advisable to know the differ-
ences between populations that will result in more focused 
research and directed policies to reduce the enormous 
problem that these non-communicable diseases represent. 
Additionally, the prevalence of risk factors is increasing in 
low- and middle-income countries, while in high-income 
countries, they have been suggested to have reached a pla-
teau [36]. Consequently, as overweight and MetS increases, 
the risk of diabetes and cardiovascular disease morbidity and 
mortality will increase in parallel in these low- and middle-
income countries [37–41]. Although, the lifestyle differ-
ences described above can explained partially the results, 
which is not clear how much these differences account for 
the demographic variations in the prevalence of the MetS, 
and overweight and obesity, and more importantly how they 
can be modified.
Strengths and limitations
Strengths of our study include that the ENSANUT-ECU 
study was performed in a very large-scale nation-wide 
Fig. 4  Mets by the socioeconomic status. *Significant differences 
between groups (p < 0.05)
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sample across the entire Ecuadorian country, using standard-
ized protocols, instruments, and biomarkers, which enables 
the exploration of the heterogeneity across age, gender, and 
geographic and socioeconomic groups. Strict training and 
supervision were performed to ensure adequate data collec-
tion. The results thus offer exceptionally informative evi-
dence on the prevalence of MetS and the sociodemographic 
determinants of the Ecuadorian society. An important limita-
tion regarding the prevalence of metabolic syndrome is that 
the study did not include the population older than 59 years. 
This means that the found MetS prevalence is probably rela-
tively low, since prevalence increases with aging. Another 
limitation is that we only measured all participants at one 
point in time and we cannot, therefore, provide evidence for 
changes in time within persons or generations.
Conclusions
In conclusion, our results showed a high prevalence of over-
weight, obesity, and the MetS in Ecuador, and that there 
are crucial differences between region, area, socioeco-
nomic status, and importantly by gender within the Ecua-
dorian population. Particularly, urban-dwelling men in the 
coastal regions of high socioeconomic state are at high risk 
to develop the MetS, while indigenous individuals living 
in the Amazon region are at the lowest risk. How this will 
impact further development of CVD in these separate popu-
lations need to be studied. Also, further studies evaluating 
the impact of diet, physical activity, socioeconomic status, 
and education could help to identify the factors responsible 
for the differences between gender, areas, and regions. Fur-
thermore, the described prevalence of different metabolic 
risk factors for each region will allow to develop more tar-
geted prevention strategies; for example, a diet strategy in 
Ecuador will be totally different between the Amazon region 
where it might be necessary to increase the HDL levels than 
for the coastal region where focus would be on reducing, in 
particular, the blood pressure.
Author contributions All authors critically reviewed the manuscript 
and read and approved the manuscript; WF provided the database of 
the ENSANUT-ECU study; JPG performed the statistical analysis; JPG 
and TV wrote the manuscript; TV, LBR, TM, HD, WF, and OHF pro-
vided input regarding the interpretation of the analyses; JPG, TV, and 
OHF had primary responsibility for the final content of the manuscript.
Funding This publication was supported by the Institutional Coopera-
tion between the higher education institutions of the Wallonia-Brussels 
Federation (Belgium) and the Universidad Central del Ecuador funded 
through the Academie de Recherche et d’Enseignement Superieur 
(ARES).
Data availability The data are available online at the web page of the 
Ecuadorian Health Ministry.
Compliance with ethical standards 
Conflict of interest The authors declare no conflict of interest.
Ethical approval Not applicable.
Informed consent Not applicable.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
Fig. 5  Mets in women and men by the socioeconomic status. a In men and b in women. *p < 0.05, **p < 0.001
Journal of Endocrinological Investigation 
1 3
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Popkin B, Adair L, Ng S (2012) NOW AND THEN: the global 
nutrition transition: the pandemic of obesity in developing coun-
tries. nutr rev 70(1):3–21
 2. Popkin BM, Adair LS, Ng SW (2012) Global nutrition transition 
and the pandemic of obesity in developing countries. Nutr Rev 
70(1):3–21. https ://doi.org/10.1111/j.1753-4887.2011.00456 .x
 3. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono 
C et al (2014) Global, regional, and national prevalence of over-
weight and obesity in children and adults during 1980–2013: 
a systematic analysis for the Global Burden of Disease Study 
2013. Lancet 384(9945):766–781
 4. Farag YMK, Gaballa MR (2011) Diabesity: an overview of a 
rising epidemic. Nephrol Dial Transplant 26(1):28–35
 5. Jaacks LM, Siegel KR, Gujral UP, Narayan KMV (2016) 
Type 2 diabetes: a 21st century epidemic. Best Pract Res Clin 
Endocrinol Metab 30(3):331–343. https ://doi.org/10.1016/j.
beem.2016.05.003
 6. Franco OH, Massaro JM, Civil J, Cobain MR, O’Malley B, 
D’Agostino RB (2009) Trajectories of entering the meta-
bolic syndrome: the framingham heart study. Circulation 
120(20):1943–1950
 7. Márquez-Sandoval F, Macedo-Ojeda G, Viramontes-Hörner D, 
Fernández Ballart J, Salas Salvadó J, Vizmanos B (2011) The 
prevalence of metabolic syndrome in Latin America: a system-
atic review. Public Health Nutr 14(10):1702–1713. https ://www.
journ als.cambr idge.org/abstr act_S1368 98001 00033 20
 8. Cuevas A, Alvarez V, Carrasco F (2011) Epidemic of metabolic 
syndrome in Latin America. Curr Opin Endocrinol Diabetes 
Obes 18(2):134–138. https ://conte nt.wkhea lth.com/linkb ack/
openu rl?sid=WKPTL P:landi ngpag e&an=01266 029-20110 
4000-00007 
 9. Food and Agriculture Organization of the United Nations (2006) 
The double burden of malnutrition, vol. 20, World Health 
Organization. https ://books .googl e.com/books ?id=mamt4 
lfXRu wC&pg=PA187 &dq=dieta ry+oil+intak e+socio econo 
mic&hl=&cd=6&sourc e=gbs_api
 10. Boissonnet C, Schargrodsky H, Pellegrini F, Macchia A, Marcet 
Champagne B, Wilson E et al (2011) Educational inequalities 
in obesity, abdominal obesity, and metabolic syndrome in seven 
Latin American cities: the CARMELA Study. Eur J Cardiovasc 
Prev Rehabil 18(4):550–556. https ://doi.org/10.1177/17418 26710 
38941 8
 11. Sempértegui F, Estrella B, Tucker KL, Hamer DH, Narvaez X, 
Sempértegui M et al (2011) Metabolic syndrome in the elderly liv-
ing in marginal peri-urban communities in Quito, Ecuador. Public 
Health Nutr 14(5):758–756 (Elderly; metabolic syndrome; Ecua-
dor; micronutrient deficiency; C-reactive protein)
 12. Paz-y-Miño C, Guillén MJ, Leone PE (2014) Genetics and 
genomic medicine in Ecuador. Mol Genet Genomic Med 2(2):85–
94. https ://doi.org/10.1002/mgg3.73
 13. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Paul 
K, Whelton JH (2005) Prevalence of the metabolic syndrome and 
overweight among adults in China. Lancet 365:8
 14. Freire W, Ramirez-Luzuriaga M, Belmont P, Mendieta M, Silva-
Jaramillo M, Romero N et al (2014) Tomo I: Encuesta Nacional de 
Salud y Nutrición de la población ecuatoriana de cero a 59 años. 
ENSANUT-ECU 2012, First. Quito, p 722
 15. Freire WB, Belmont P, Lepez-Cevallos DF, Waters WF (2015) 
Ecuador’s national health and nutrition survey: objectives, 
design, and methods. Ann Epidemiol. 25(11):877–878. https ://
doi.org/10.1016/j.annep idem.2015.08.009
 16. De Onis M, Habicht JP (1996) Anthropometric reference data for 
international use: recommendations from a World Health Organi-
zation Expert Committee. Am J Clin Nutr 64(4):650–658
 17. The Obesity Society (1998) Guidelines for management of the 
obese and overweight. Obes Res 6:51S–179S
 18. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, 
Donato KA et al (2009) Harmonizing the metabolic syndrome: a 
joint interim statement of the international diabetes federation task 
force on epidemiology and prevention; National heart, lung, and 
blood institute; American heart association; World heart federa-
tion. Int Circ 120(16):1640–1645
 19. Instituto Nacional de Estadística y Censos (INEC) (2017) 
Resultados|Instituto Nacional de Estadística y Censos. https ://
www.ecuad orenc ifras .gob.ec/resul tados /. Accessed 28 Jun 2017
 20. Del Brutto OH, Mera RM, Ha J, Gillman J, Zambrano M, Castillo 
PR (2016) Dietary fish intake and sleep quality: a population-
based study. Sleep Med 17:126–128. https ://linki nghub .elsev ier.
com/retri eve/pii/S1389 94571 50202 25
 21. Tørris C, Molin M, Smastuen MC (2014) Fish consumption and 
its possible preventive role on the development and prevalence of 
metabolic syndrome-a systematic review. Diabetol Metab Syndr 
6:1
 22. Ve W, Lichtenstein AH, Welty FK, Li Z, Lamon-fava S, Dol-
nikowski GG et al (1999) Decreases HDL ApoA-I secretion. Arte-
rioscl Thromb Vasc Biol 1999:918–925
 23. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-
Hansen A (2004) Genetic variation in ABC transporter A1 con-
tributes to HDL cholesterol in the general population. J Clin Inves-
tig 114(9):1343–1353. https ://www.jci.org/artic les/view/20361 
 24. de Carvalho-Vidigal F, Bressan J, Babio N, Salas-Salvadó J (2013) 
Prevalence of metabolic syndrome in Brazilian adults: a system-
atic review. BMC Public Health 13:1198
 25. Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza 
H, Talaei M, Ng S-K et al (2017) Secular trend of metabolic syn-
drome and its components in a cohort of Iranian adults from 2001 
to 2013. Metab Syndr Relat Disord 15(3):137–144. https ://doi.
org/10.1089/met.2016.0073
 26. Ponce X, Rodríguez-Ramírez S, Mundo-Rosas V, Shamah T, 
Barquera S, De Cossio TG (2014) Dietary quality indices vary 
with sociodemographic variables and anthropometric status 
among mexican adults: a cross-sectional study. Results from the 
2006 national health and nutrition survey. Public Health Nutr 
17(8):1717–1728
 27. Chakraborty S, Roy S, Rahaman M (2015) Epidemiological 
predictors of metabolic syndrome in urban West Bengal, India. 
J Fam Med Prim Care 4(4):535. https ://www.jfmpc .com/text.
asp?2015/4/4/535/17427 9
 28. Adedoyin RA, Afolabi A, Adegoke OO, Akintomide AO, Awo-
tidebe TO (2013) Relationship between socioeconomic sta-
tus and metabolic syndrome among Nigerian adults. Diabetes 
Metab Syndr Clin Res Rev 7(2):91–94. https ://doi.org/10.1016/j.
dsx.2013.02.014
 29. Gannar F, Cabrera de León A, Brito Díaz B, Del Cristo Rodríguez 
Pérez M, Marcelino Rodríguez I, Ben Dahmen F et al (2015) 
Social class and metabolic syndrome in populations from Tuni-
sia and Spain. Diabetol Metab Syndr 7(1):88. https ://www.dmsjo 
urnal .com/conte nt/7/1/88
 30. Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, 
Kaufman HW et al (2016) Neighborhood socioeconomic status in 
relation to serum biomarkers in the Black Women’s Health Study. 
J Urban Heal New York Acad Med 93(2):279–291
 Journal of Endocrinological Investigation
1 3
 31. Zhan Y, Yu J, Chen R, Gao J, Ding R, Fu Y et al (2012) Socioeco-
nomic status and metabolic syndrome in the general population 
of China: a cross-sectional study. BMC Public Health 12(1):921. 
https ://doi.org/10.1186/1471-2458-12-921
 32. Blanquet M, Debost-Legrand A, Gerbaud L, De La Celle C, Brig-
and A, Mioche L et al (2016) Metabolic syndrome and social 
deprivation: results of a French observational multicentre survey. 
Fam Pract 33(1):17–22
 33. Chichlowska KL, Rose KM, Diez-Roux AV, Golden SH, McNeill 
AM, Heiss G (2009) Life course socioeconomic conditions and 
metabolic syndrome in adults: the atherosclerosis risk in com-
munities (ARIC) study. Ann Epidemiol 19(12):875–883. https ://
doi.org/10.1016/j.annep idem.2009.07.094
 34. Wu HF, Tam T, Jin L, Lao XQ, Chung RYN, Su XF et al (2017) 
Age, gender, and socioeconomic gradients in metabolic syndrome: 
biomarker evidence from a large sample in Taiwan, 2005–2013. 
Ann Epidemiol 27(5):315–322.e2. https ://doi.org/10.1016/j.annep 
idem.2017.04.003
 35. Wells JCK, Cole TJ, Bruner D, Treleaven P (2008) Body shape 
in American and British adults: between-country and inter-ethnic 
comparisons. Int J Obes 32(1):152–159. https ://doi.org/10.1038/
sj.ijo.08036 85
 36. World Health Organization. Global status report on noncommu-
nicable diseases (2010) World Health, p 176. https ://whqli bdoc.
who.int/publi catio ns/2011/97892 40686 458_eng.pdf
 37. Galassi A, Reynolds K, He J (2006) Metabolic syndrome and 
risk of cardiovascular disease: a meta-analysis. Am J Med 
119(10):812–819
 38. Thorn LM, Forsblom C, Waden J, Saraheimo M, Tolonen N, 
Hietala KU, Groop PH (2009) Metabolic syndrome as a risk factor 
for cardiovascular disease, mortality, and progression of diabetic 
nephropathy in type 1 diabetes. Diabetes Care 2009:950–952
 39. Marion AW, Baker AJ, Dhawan A, Wild SH, Byrne CD (2004) 
Fatty liver disease in children. Arch Dis Child. 333:648–652
 40. Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS, Park YM et al 
(2013) Metabolic syndrome as a predictor of type 2 diabetes, 
and its clinical interpretations and usefulness. J Diabetes Investig 
4(4):334–343
 41. Neergaard JS, Laursen JM, Hansen HB, Christiansen C, Beck-
nielsen H, Karsdal MA et al (2016) Metabolic syndrome and 
subsequent risk of type 2 diabetes and cardiovascular disease in 
elderly women. Med 2016:36
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
